Kura Oncology Inc (KURA) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Kura Oncology Inc   (NASDAQ: KURA)

Kura Oncology Inc

Officers & Directors


1. Troy E. Wilson, Ph.D., J.D.
President, Chief Executive Officer, and Chairman of the Board of Directors. Troy E. Wilson co-founded Kura Oncology in 2014 and has served as CEO since its inception. He has more than 20 years of experience in drug discovery and development.

2. Helen Collins, M.D.
Director.

3. Mary Szela
Director.

4. Diane Parks
Director.

5. Thomas Doyle
Senior Vice President, Finance.

6. Thomas Malley
Director.

7. Carol Schafer
Director.

8. Faheem Hasnain
Director.,

Kura Oncology Inc currently has 260 employees.






KURA Management Effectiveness KURA Revenue per Employee KURA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.